Dr. Anand K. Sharma, MD

Dr. Sharma practices at HCA Healthcare Trident Hospital in Charleston, South Carolina, part of HCA Healthcare.

Dr. Sharma's NPI, 1043264369, was assigned on May 20, 2006. Dr. Sharma graduated from Jawaharlal Nehru Medical College, Aligarh Muslim University in 1983. Dr. Sharma holds South Carolina license 22526.

Dr. Sharma's primary practice is HCA Healthcare Trident Hospital, at 9330 Medical Plaza Dr, Charleston, SC 29406 in Charleston County. The practice phone is (843) 847-4100.

Dr. Sharma's primary practice is HCA Healthcare Trident Hospital in Charleston, South Carolina, part of HCA Healthcare. Dr. Sharma is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Sharma to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sharma practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Sharma's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Sharma is board certified in radiation oncology by the American Board of Radiology. Dr. Sharma is licensed in South Carolina.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, head & neck cancer radiation, lung cancer radiation, lymphoma radiation and prostate cancer radiation among the conditions Dr. Sharma treats.

CMS data shows 1,611 Medicare services from Dr. Sharma across 14 procedure codes in 2024, for 176 Medicare patients. Medicare paid $99,256 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 176 Medicare patients who saw Dr. Sharma in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sharma's median patient age at 73, with 39% women.

In 2024, Dr. Sharma wrote 74 Medicare Part D claims for 46 patients. 89% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $305 in total drug cost. In 2023, CMS named 54 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Sharma for performance year 2024, reported as part of a group. Dr. Sharma accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 60 papers to Dr. Sharma, published from 2009 to 2023. 2021 was the busiest year, with 6. The most frequent topics are Carcinoma, Squamous Cell, Head and Neck Neoplasms and Squamous Cell Carcinoma of Head and Neck. Dr. Sharma has published most often in Head Neck. Dr. Sharma's most frequent co-authors are Evan Michael Graboyes, MD, John Michael Kaczmar, MD and Shaun A. Nguyen, MD.

Dmand AI links Dr. Sharma to 8 clinical trials, 3 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms and Carcinoma, Squamous Cell. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 27 general payments to Dr. Sharma from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $135.

Dmand AI lists 1 award for Dr. Sharma, most recently CMS Stage 1 EHR in 2013.

Dr. Sharma graduated from Jawaharlal Nehru Medical College, Aligarh Muslim University in 1983.

Dr. Sharma is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.